Earnings Scheduled For November 8, 2022
Companies Reporting Before The Bell
• Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
Gainers
ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders.
US Stocks Flat, Crude Oil Rises 2%
U.S. stocks traded almost flat in volatile trading on Thursday following the release of jobless claims data.
AeroVironment, Snap And Some Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording gains in today’s session.
Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners.
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
Gainers
Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS.
Coinbase, Trade Desk, H&R Block And Some Other Big Gainers From Wednesday
U.S. stocks closed higher on Wednesday following the release of inflation data. Here is the list of some big stocks moving higher in the previous session.
LifeStance Health Group Q2 EPS $(0.19) Misses $(0.14) Estimate, Sales $209.50M Miss $212.23M Estimate
LifeStance Health Group (NASDAQ:LFST) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.14) by 35.71 percent. This is a 13.64 percent increase over losses of $(0.22) per
Earnings Scheduled For August 9, 2022
Companies Reporting Before The Bell
• Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.
Morgan Stanley Maintains Equal-Weight on LifeStance Health Gr, Lowers Price Target to $8
Morgan Stanley analyst Ricky Goldwasser maintains LifeStance Health Gr (NASDAQ:LFST) with a Equal-Weight and lowers the price target from $10 to $8.